Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia - No Study Results Posted

Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia (CONNECT)

This study has been terminated.

( Following a pre-specified interim analysis and Data Monitoring Committee recommendation due to insufficient level of efficacy )

Study NCT00439634 Information provided by Sanofi-Aventis

First Received: February 22, 2007 Last Updated: October 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	October 2009
Primary Completion Date:	October 2009 (Final data collection date for primary outcome measure)